Silence Therapeutics (SLN) Earnings Date & Reports

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

SLN is expected to report earnings to rise 11.14% to -7 cents per share on March 13

Silence Therapeutics SLN Stock Earnings Reports

Q4'23

Est.

$-0.08

Q3'23

Beat

by $0.10

Q2'23

Beat

by $0.05

Q1'23

Beat

by $0.03

Q4'22

Beat

by $0.46

The last earnings report on November 14 showed earnings per share of -7 cents, beating the estimate of -17 cents. With 118.66K shares outstanding, the current market capitalization sits at 120.42M.

View a ticker or compare two or three

Compare

SLN